
Heidi L. Reese
Examiner (ID: 13855)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1657, 1625, 1622 |
| Total Applications | 1608 |
| Issued Applications | 1298 |
| Pending Applications | 5 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13968179
[patent_doc_number] => 10213422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Compositions and methods of inhibiting histone deacetylases
[patent_app_type] => utility
[patent_app_number] => 15/124246
[patent_app_country] => US
[patent_app_date] => 2015-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 52
[patent_no_of_words] => 10696
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15124246
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/124246 | Compositions and methods of inhibiting histone deacetylases | Apr 12, 2015 | Issued |
Array
(
[id] => 11772428
[patent_doc_number] => 09381181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Treatment of NAFLD and NASH'
[patent_app_type] => utility
[patent_app_number] => 14/684100
[patent_app_country] => US
[patent_app_date] => 2015-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4473
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14684100
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/684100 | Treatment of NAFLD and NASH | Apr 9, 2015 | Issued |
Array
(
[id] => 12466056
[patent_doc_number] => 09987258
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Histone deacetylase as a modulator of PDL1 expression and activity
[patent_app_type] => utility
[patent_app_number] => 15/120065
[patent_app_country] => US
[patent_app_date] => 2015-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 55
[patent_no_of_words] => 11147
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15120065
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/120065 | Histone deacetylase as a modulator of PDL1 expression and activity | Apr 5, 2015 | Issued |
Array
(
[id] => 12562557
[patent_doc_number] => 10016421
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccination
[patent_app_type] => utility
[patent_app_number] => 15/120053
[patent_app_country] => US
[patent_app_date] => 2015-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 23
[patent_no_of_words] => 7030
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15120053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/120053 | Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccination | Apr 5, 2015 | Issued |
Array
(
[id] => 11704445
[patent_doc_number] => 20170172944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'METHODS OF TREATING MELANOMA'
[patent_app_type] => utility
[patent_app_number] => 15/300642
[patent_app_country] => US
[patent_app_date] => 2015-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12250
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15300642
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/300642 | METHODS OF TREATING MELANOMA | Mar 31, 2015 | Abandoned |
Array
(
[id] => 11183749
[patent_doc_number] => 09415134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-16
[patent_title] => 'Fosfomycin preparation, a method for producing the preparation, and a polymethylmethacrylate bone cement powder containing the preparation'
[patent_app_type] => utility
[patent_app_number] => 14/673922
[patent_app_country] => US
[patent_app_date] => 2015-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4442
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14673922
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/673922 | Fosfomycin preparation, a method for producing the preparation, and a polymethylmethacrylate bone cement powder containing the preparation | Mar 30, 2015 | Issued |
Array
(
[id] => 10649314
[patent_doc_number] => 09365550
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-14
[patent_title] => 'Benzimidazoles as CNS active agents'
[patent_app_type] => utility
[patent_app_number] => 14/675404
[patent_app_country] => US
[patent_app_date] => 2015-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8541
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14675404
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/675404 | Benzimidazoles as CNS active agents | Mar 30, 2015 | Issued |
Array
(
[id] => 10414217
[patent_doc_number] => 20150299227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/671452
[patent_app_country] => US
[patent_app_date] => 2015-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36822
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14671452
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/671452 | Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders | Mar 26, 2015 | Issued |
Array
(
[id] => 10412505
[patent_doc_number] => 20150297514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'INHALATION-TYPE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF LUNG CANCER AND PREPARATION METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/666037
[patent_app_country] => US
[patent_app_date] => 2015-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4277
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14666037
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/666037 | Inhalation-type pharmaceutical composition for the treatment of lung cancer and preparation method thereof | Mar 22, 2015 | Issued |
Array
(
[id] => 10387861
[patent_doc_number] => 20150272868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'INHALATION-TYPE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEART DISEASE AND PREPARATION METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/664491
[patent_app_country] => US
[patent_app_date] => 2015-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4258
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14664491
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/664491 | Inhalation-type pharmaceutical composition for the treatment of heart disease and preparation method thereof | Mar 19, 2015 | Issued |
Array
(
[id] => 10387862
[patent_doc_number] => 20150272869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'INHALATION-TYPE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ARTHRITIS AND PREPARATION METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/664508
[patent_app_country] => US
[patent_app_date] => 2015-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4188
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14664508
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/664508 | Inhalation-type pharmaceutical composition for the treatment of arthritis and preparation method thereof | Mar 19, 2015 | Issued |
Array
(
[id] => 11772402
[patent_doc_number] => 09381152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Inhalation-type pharmaceutical composition for the treatment of Parkinson\'s disease and preparation method thereof'
[patent_app_type] => utility
[patent_app_number] => 14/664465
[patent_app_country] => US
[patent_app_date] => 2015-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4360
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14664465
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/664465 | Inhalation-type pharmaceutical composition for the treatment of Parkinson's disease and preparation method thereof | Mar 19, 2015 | Issued |
Array
(
[id] => 10387860
[patent_doc_number] => 20150272867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'INHALATION-TYPE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER\'S DISEASE AND PREPARATION METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/664483
[patent_app_country] => US
[patent_app_date] => 2015-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4188
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14664483
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/664483 | Inhalation-type pharmaceutical composition for the treatment of Alzheimer's disease and preparation method thereof | Mar 19, 2015 | Issued |
Array
(
[id] => 10374286
[patent_doc_number] => 20150259292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS'
[patent_app_type] => utility
[patent_app_number] => 14/663347
[patent_app_country] => US
[patent_app_date] => 2015-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 44032
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14663347
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/663347 | Heterocyclic modulators of lipid synthesis | Mar 18, 2015 | Issued |
Array
(
[id] => 11762974
[patent_doc_number] => 09371331
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-21
[patent_title] => 'Modulators of methyl modifying enzymes, compositions and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/661797
[patent_app_country] => US
[patent_app_date] => 2015-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 118
[patent_figures_cnt] => 1
[patent_no_of_words] => 95465
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14661797
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/661797 | Modulators of methyl modifying enzymes, compositions and uses thereof | Mar 17, 2015 | Issued |
Array
(
[id] => 13153933
[patent_doc_number] => 10093678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Azaspiro derivatives as TRPM8 antagonists
[patent_app_type] => utility
[patent_app_number] => 15/125615
[patent_app_country] => US
[patent_app_date] => 2015-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43649
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 374
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15125615
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/125615 | Azaspiro derivatives as TRPM8 antagonists | Mar 15, 2015 | Issued |
Array
(
[id] => 11065433
[patent_doc_number] => 20160262397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'EQUINE HOOF TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/645685
[patent_app_country] => US
[patent_app_date] => 2015-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 658
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645685
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/645685 | EQUINE HOOF TREATMENT | Mar 11, 2015 | Abandoned |
Array
(
[id] => 10297514
[patent_doc_number] => 20150182513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents'
[patent_app_type] => utility
[patent_app_number] => 14/656123
[patent_app_country] => US
[patent_app_date] => 2015-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75086
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14656123
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/656123 | N-link hydroxamic acid derivatives useful as antibacterial agents | Mar 11, 2015 | Issued |
Array
(
[id] => 10614831
[patent_doc_number] => 09334265
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => '3-amino-pyrazole derivatives useful against tuberculosis'
[patent_app_type] => utility
[patent_app_number] => 14/639241
[patent_app_country] => US
[patent_app_date] => 2015-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25959
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14639241
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/639241 | 3-amino-pyrazole derivatives useful against tuberculosis | Mar 4, 2015 | Issued |
Array
(
[id] => 10192914
[patent_doc_number] => 09221810
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-29
[patent_title] => 'Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/637223
[patent_app_country] => US
[patent_app_date] => 2015-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42124
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14637223
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/637223 | Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors | Mar 2, 2015 | Issued |